Real-world outcomes of patients with severe asthma treated with mepolizumab by baseline inhaled corticosteroid dose: Post hoc analysis of realiti-a at 2 years

被引：0
|
作者：
Smith, A. [1 ]
Patel, M. [1 ]
Caruso, C. [2 ]
Pilette, C. [3 ]
Welte, T. [4 ]
Alfonso-Cristancho, R. [5 ]
Price, R. G. [6 ]
Howarth, P. [7 ]
机构：
[1] Univ Hosp Wishaw, Wishaw, Scotland
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] Clin Univ St Luc, Brussels, Belgium
[4] Hannover Med Sch, Hannover, Germany
[5] GSK, Collegeville, PA USA
[6] GSK, Stevenage, Herts, England
[7] GSK, Brentford, Middx, England
来源：
ALLERGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
000854
引用
收藏
页码：50 / 51
页数：2
相关论文
共 50 条
  • [21] The impact of comorbid nasal polyps on real-world mepolizumab effectiveness in patients with severe asthma: Results from the REALITI-A study
    Liu, Mark C.
    Bagnasco, Diego
    Matucci, Andrea
    Pilette, Charles
    Price, Robert G.
    Maxwell, Aoife C.
    Alfonso-Cristancho, Rafael
    Jakes, Rupert W.
    Yang, Shibing
    Howarth, Peter
    Cheema, Amarjit S.
    ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 566 - 566
  • [22] Asthma Control in Patients with Severe Eosinophilic Asthma Treated with Mepolizumab in Real-Life Settings: The Prospective, REALITI-A Study
    Chaudhuri, R.
    Canonica, G. W.
    Bals, R.
    Lougheed, M. D.
    Pilette, C.
    Ramos-Barbon, D.
    Pollard, S.
    Maxwell, A.
    Worsley, S.
    Van Dyke, M. K.
    Joksaite, S.
    Howarth, P.
    Cristancho, R. Alfonso
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [23] The Clinical Benefit Of Mepolizumab Treatment Is Independent Of Baseline Maintenance Oral Corticosteroid Use: Results From The Real-World REALITI-A Study
    Liu, Mark
    Schleich, Florence
    Lee, Jason
    Pelaia, Girolamo
    Sanchez, Carlos Almonacid
    Heaney, Liam
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Price, Robert
    Maxwell, Aoife
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB147 - AB147
  • [24] THE SUSTAINED OCS-SPARING EFFECT OF MEPOLIZUMAB: RESULTS FROM THE REAL-WORLD REALITI-A STUDY AT 2 YEARS
    Pollard, S.
    Offenberger, J.
    Lee, F.
    Liu, M.
    Alfonso-Cristancho, R.
    Price, R.
    Howarth, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S43 - S43
  • [25] Influence of Baseline Total IgE and History of Previous Omalizumab Use on the Impact of Mepolizumab in Reducing Rate of Severe Asthma Exacerbations: Results From the Real-World REALITI-A Study
    Lee, Jason
    Pollard, Stephen
    Liu, Mark
    Schleich, Florence
    Pelaia, Girolamo
    Almonacid, Carlos
    Heaney, Liam
    Chaudhuri, Rekha
    Alfonso-Cristancho, Rafael
    Jakes, Rupert
    Price, Robert
    Maxwell, Aoife
    Howarth, Peter
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB191 - AB191
  • [26] Baseline Characteristics of Patients With Severe Asthma Treated With Mepolizumab: An Interim Analysis of a Multi-country Real-world Cohort
    Allehebi, R. O.
    Maturu, V. Nagarjuna
    Mahboub, B.
    Bavbek, S.
    Fernandez, P.
    Rosales, D. Cano
    Soares, C.
    Abreu, G.
    Valladares, R.
    Queiroz, J.
    Menezes, P.
    Raimondi, A.
    Aziz, F.
    Pizzichini, E.
    Laucho-Contreras, M.
    Noibi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [27] MEPOLIZUMAB IMPACT ON HEALTHCARE RESOURCE UTILIZATION AND WORK PRODUCTIVITY IN PATIENTS WITH SEVERE ASTHMA: REALITI-A 2-YEAR ANALYSIS
    Canonica, G. W.
    Howarth, P.
    Alfonso-Cristancho, R.
    Penz, E.
    Zhang, L.
    Bourdin, A.
    VALUE IN HEALTH, 2024, 27 (06) : S91 - S91
  • [28] Mepolizumab Reduces Clinically Significant Exacerbations in Patients With Severe Asthma Prior to and During the COVID-19 Pandemic: Results From the Real-world REALITI-A Study
    Schleich, F.
    Lougheed, M.
    Matucci, A.
    Hermosa, J. Rodriguez
    Pfeffer, P.
    Verghis, R. M.
    Jakes, R. W.
    Alfonso-Cristancho, R.
    Liu, M. C.
    Welte, T.
    Bals, R.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [29] How Real-World Mepolizumab Users in the REALITI-A Study Relate to the Recruitment Criteria Applied in the Randomized, Placebo-Controlled Trials of Subcutaneous Mepolizumab in Severe Eosinophilic Asthma
    Ramos-Barbon, D.
    Bals, R.
    Crimi, N.
    Menzies, D.
    Pek, B.
    Pilette, C.
    Steven, G.
    Alfonso-Cristancho, R.
    Jakes, R.
    Maxwell, A. C.
    Price, R. G.
    Yang, S.
    Howarth, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [30] WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT IN PATIENTS WITH SEVERE ASTHMA TREATED WITH MEPOLIZUMAB IN A REAL-WORLD SETTING
    Alfonso-Cristancho, R.
    Canonica, W.
    Price, R. G.
    Yang, S.
    Jakes, R. W.
    Maxwell, A.
    Howarth, P.
    VALUE IN HEALTH, 2022, 25 (07) : S567 - S567
12345